
कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
GILD | NASDAQ | USD | रियल टाइम | |
GILD | मेक्सिको | MXN | देरी | |
GGILD | मिलान | EUR | रियल टाइम | |
GILD | Xetra | EUR | देरी | |
GILD | फ़्रंकफ़र्ट | EUR | देरी | |
GILD | ट्रेडगेट | EUR | देरी | |
GILD | ब्यूनस आयर्स | ARS | देरी | |
GILD | विएना | EUR | रियल टाइम | |
GILD | लिमा | USD | देरी |
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Merck & Co, Inc., and Tentarix Biotherapeutics Inc., as well as a partnership with Assembly Biosciences, Inc. to develop next-generation therapeutics for serious viral diseases. The company was incorporated in 1987 and is headquartered in Foster City, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Daniel P. O'Day | 57 | 2019 | Chairman & CEO |
Paul Berg | 96 | 1998 | Member of Scientific Advisory Board |
Grace E. Colon | 56 | 2023 | Chairman of the Board |
Francis V. Chisari | - | - | Member of the Scientific Advisory Board |
Brian J. Druker | 67 | - | Member of the Scientific Advisory Board |
Jacqueline K. Barton | 70 | 1989 | Independent Director |
Kevin E. Lofton | 68 | 2009 | Lead Independent Director |
Robert T. Schooley | - | - | Member of the Scientific Advisory Board |
Kenneth C. Anderson | 72 | - | Member of the Scientific Advisory Board |
Mark C. Genovese | - | - | Member of Scientific Advisory Board |
Eugene R. Schiff | - | - | Member of the Scientific Advisory Board |
John W. Mellors | 85 | - | Member of the Scientific Advisory Board |
Eric J. Topol | 69 | - | Member of Scientific Advisory Board |
Robert A. Harrington | 62 | - | Member of the Scientific Advisory Board |
Paul E. Klotman | - | - | Member of the Scientific Advisory Board |
Harish M. Manwani | 70 | 2018 | Independent Director |
Javier J. Rodriguez | 52 | 2020 | Independent Director |
Joel R. Huff | - | - | Chairperson of Scientific Advisory Board |
Malcolm MacCoss | 75 | - | Member of Scientific Advisory Board |
Kelly A. Kramer | 55 | 2016 | Independent Director |
Nezam H. Afdhal | 66 | - | Member of Scientific Advisory Board |
Jeffrey A. Bluestone | 70 | 2020 | Independent Director |
Sandra J. Horning | 74 | 2020 | Independent Director |
Anthony Welters | 68 | 2020 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है